Articles with public access mandates - David MischoulonLearn more
Not available anywhere: 34
Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression
AA Nierenberg, JE Alpert, EE Gardner-Schuster, S Seay, D Mischoulon
Biological psychiatry 64 (6), 455-460, 2008
Mandates: US National Institutes of Health
Circulating microRNAs as biomarkers for depression: many candidates, few finalists
H Yuan, D Mischoulon, M Fava, MW Otto
Journal of affective disorders 233, 68-78, 2018
Mandates: US National Institutes of Health
A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression
D Mischoulon, AA Nierenberg, PJ Schettler, BL Kinkead, K Fehling, ...
The Journal of clinical psychiatry 76 (1), 4830, 2014
Mandates: US National Institutes of Health
Clinical features and functioning of patients with minor depression
RH Howland, PJ Schettler, MH Rapaport, D Mischoulon, T Schneider, ...
Psychotherapy and Psychosomatics 77 (6), 384-389, 2008
Mandates: US National Institutes of Health
St John’s wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT
J Sarris, M Fava, I Schweitzer, D Mischoulon
Pharmacopsychiatry 45 (07), 275-278, 2012
Mandates: US National Institutes of Health, National Health and Medical Research …
A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder
AS Yeung, VE Ameral, SE Chuzi, M Fava, D Mischoulon
Journal of Affective Disorders 130 (1-2), 285-289, 2011
Mandates: US National Institutes of Health
A pilot study of acupuncture monotherapy in patients with major depressive disorder
D Mischoulon, CD Brill, VE Ameral, M Fava, AS Yeung
Journal of affective disorders 141 (2-3), 469-473, 2012
Mandates: US National Institutes of Health
Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial
J Sarris, GJ Byrne, C Bousman, C Stough, J Murphy, P MacDonald, ...
European Neuropsychopharmacology 28 (10), 1126-1136, 2018
Mandates: National Health and Medical Research Council, Australia
Screening for suicide risk in the college population
A Farabaugh, M Nyer, D Holt, L Baer, S Petrie, M DiPierro, A Nierenberg, ...
Journal of Rational-Emotive & Cognitive-Behavior Therapy 33, 78-94, 2015
Mandates: US National Institutes of Health
EPA and DHA as markers of nutraceutical treatment response in major depressive disorder
KP van der Burg, L Cribb, J Firth, D Karmacoska, D Mischoulon, GJ Byrne, ...
European Journal of Nutrition 59, 2439-2447, 2020
Mandates: National Health and Medical Research Council, Australia
S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial
J Sarris, J Murphy, C Stough, D Mischoulon, C Bousman, P MacDonald, ...
Psychopharmacology 237, 209-218, 2020
Mandates: National Health and Medical Research Council, Australia
Omega-3 fatty acids for major depressive disorder with high inflammation: a randomized dose-finding clinical trial
D Mischoulon, BW Dunlop, B Kinkead, PJ Schettler, S Lamon-Fava, ...
The Journal of Clinical Psychiatry 83 (5), 42432, 2022
Mandates: US National Institutes of Health
Very low-level transcranial photobiomodulation for major depressive disorder: the ELATED-3 multicenter, randomized, sham-controlled trial
DV Iosifescu, RJ Norton, U Tural, D Mischoulon, K Collins, E McDonald, ...
The Journal of Clinical Psychiatry 83 (5), 42180, 2022
Mandates: US National Institutes of Health
A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder
TW Guu, D Mischoulon, J Sarris, J Hibbeln, RK McNamara, K Hamazaki, ...
Journal of affective disorders 265, 233-238, 2020
Mandates: National Health and Medical Research Council, Australia, UK Medical Research …
Yoga for the treatment of depression: Five questions to move the evidence-base forward
M Nauphal, D Mischoulon, L Uebelacker, C Streeter, M Nyer
Complementary therapies in medicine 46, 153-157, 2019
Mandates: US National Institutes of Health
Anger attacks are associated with persistently elevated irritability in MDD: findings from the EMBARC study
MK Jha, M Fava, A Minhajuddin, CC Fatt, D Mischoulon, N Wakhlu, ...
Psychological Medicine 51 (8), 1355-1363, 2021
Mandates: US National Institutes of Health
Association of anger attacks with suicidal ideation in adults with major depressive disorder: findings from the EMBARC study
MK Jha, M Fava, A Minhajuddin, C Chin Fatt, D Mischoulon, C Cusin, ...
Depression and anxiety 38 (1), 57-66, 2021
Mandates: US National Institutes of Health
Ziprasidone augmentation of escitalopram for major depressive disorder: cardiac, endocrine, metabolic, and motoric effects in a randomized, double-blind, placebo-controlled study
D Mischoulon, RC Shelton, L Baer, WV Bobo, L Curren, M Fava, ...
The Journal of Clinical Psychiatry 78 (4), 19083, 2017
Mandates: US National Institutes of Health
Cross-national differences in hypochondriasis symptoms between Korean and American outpatients with major depressive disorder
KAJ Chang, K Kim, M Fava, D Mischoulon, JP Hong, DJH Kim, JY Heo, ...
Psychiatry research 245, 127-132, 2016
Mandates: US National Institutes of Health
Conditional probability of response or nonresponse of placebo compared with antidepressants or St John’s Wort in major depressive disorder
J Sarris, AA Nierenberg, I Schweitzer, JE Alpert, JF Rosenbaum, ...
Journal of clinical Psychopharmacology 33 (6), 827-830, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program